
Molten Ventures participates in Series B funding round for Evonetix
Molten Ventures participates in Series B funding round for synthetic biology company Evonetix.
We invest in Europe's tech leaders at Series A and beyond to make more possible. More from hardware, more from software, more from healthcare, more for consumers... the hardest tech problems are just the biggest business opportunities.
Molten Ventures participates in Series B funding round for synthetic biology company Evonetix.
Molten Ventures today announces that it has led a $7 million growth round in Apperio, a leading provider of legal spend analytics and matter tracking software.
We are delighted to announce that Molten has co-led a Series A funding round into the cybersecurity company Vaultree, bringing the company’s total funding to $16 million.
We are pleased to announce that Molten has syndicated part of its Fund of Funds programme to Castlegate Investments, the private family office investment vehicle of serial entrepreneur, Tommy Kelly.
We are today excited to announce that Molten has participated in BeZero's $50 million Series B round.
We are pleased to announce that Molten has led a funding round in Worldr – the zero trust architecture for the world’s most popular communications platforms – bringing the company's total seed funding to $11 million.